Revlon Celebrates Continued Contribution to Eradicate Breast Cancer for Good

Industry Influencers Come Together to Support the Revlon Women’s
Health Mission and Honor Dr. Dennis J. Slamon’s Work at the Revlon/UCLA
Women’s Cancer Research Program

NEW YORK–(BUSINESS WIRE)–Revlon is proud to announce that it has made a $1 million donation to
the Revlon/UCLA Women’s Cancer Research Program to continue their
groundbreaking research in hope to eradicate cancer for good. The
donation was made by Revlon Chairman Ronald O. Perelman and Revlon CEO
Fabian Garcia at their annual philanthropic luncheon in support of the
Revlon’s Women Health Mission on Tuesday, September 27th in
Los Angeles, bringing Revlon’s total contribution to the program to over
$50 million, and their cumulative commitment to over $150 million.


The luncheon honored Dr. Dennis J. Slamon, M.D., Ph.D., and Director of
the Revlon/UCLA Women’s Cancer Research Program at UCLA’s Jonsson
Comprehensive Cancer Center, for his outstanding achievements in cancer
research, and was co-hosted by Rashida Jones, Peggy Lipton, Cassandra
Grey, Barbara Schumsky, Kelly Meyer, Jennifer Meyer, Sarah Meyer, Carson
Meyer, Shelli Azoff and Allison Azoff Statter. Attendees included Revlon
Global Brand Ambassador Halle Berry and Almay Global Brand Ambassador
Elaine Irwin, along with Ciara, Courteney Cox, Cindy Crawford, Melanie
Griffith, Julianne Hough, Jennifer Hudson and Anjelica Huston among
others.

“Over the past 25 years, I am proud to say that Dr. Slamon and the
Revlon Women’s Cancer Program have developed therapeutics, which are now
suitable to target and treat over 80% of breast cancers,” said Ronald O.
Perelman, Chairman of Revlon. “Only last year, the FDA designated Dr.
Slamon’s latest development, Ibrance, ‘a breakthrough therapy,’ and
fast-tracked its release to start saving the lives of women. This drug
alone has the power to help over 60% of women affected by breast cancer.”

Dr. Slamon has recognized that targeted therapies specific to a given
molecular alteration, like Herceptin for HER2 and Ibrance for cdk-4/6,
may be equally effective against the same mutations and/or proteins
across a variety of disease sites. Similarly, Ibrance shows promise
against several different malignancies, including ovarian cancer and
some types of sarcoma.

“Until recently, significant advances in cancer research were relatively
rare and took more than 17 years to move from the laboratory to the
clinic where they can impact patients,” said Margaret Steele, Executive
Director at UCLA’s Jonsson Cancer Center Foundation. “Innovations in
technology and refinements in our understanding of defined molecular
subtypes of cancer have reduced the timeframe for developing a new
cancer treatment to as little as five years, making this a particularly
exciting time to invest in scientific efforts that could improve the
lives of patients faster than ever before. We are profoundly grateful
for Revlon’s continued partnership in this life-changing work,” added
Ms. Steele.

Kara Dolce, breast cancer survivor and founder of Fighting
Pretty
, spoke at the luncheon about her personal battle with breast
cancer. After being diagnosed at the young age of 26 with stage 3 breast
cancer, she went on to have a double mastectomy, chemotherapy,
radiation, fertility treatments (egg retrieval), and 1 year of Herceptin
treatments. Thanks to Dr. Slamon’s groundbreaking research, Kara is now
cancer free and committed to inspiring women of all ages, battling any
type of cancer, to feel strong and beautiful through her non-profit,
Fighting Pretty. Plus, she is employed by the OHSU Knight Cancer
Institute in Portland, Oregon to educate patients about cancer research
and local cancer care. In an effort to support Kara’s organization,
Revlon will be donating products to Fighting Pretty’s Pretty Packages
that are sent to women undergoing treatment for a beauty “pick me up.”

New York City artist Curtis Kulig, who first gained notoriety with his
signature ‘Love Me’ manifesto, offered his support at the luncheon by
creating a one-of-a-kind painting entitled, Love, Love Love,
inspired by the Revlon Women’s Health Mission and the work of Dr.
Slamon. This unique work will be available for bidding online starting
October 25th on Paddle8.com with all proceeds going to the Revlon/UCLA
Breast Cancer Center.

Revlon also announced that their 2nd annual Revlon
LOVE IS ON Million Dollar Challenge
crowd-funding competition began
earlier this month. The Challenge was created to generate donations for
charities dedicated to women’s health issues and empower organizations
that are making a real difference in women’s lives. The 6-week online
fundraising competition lives on CrowdRise.com and runs through October
26th. The organization that raises the most money will win a $1 million
donation from Revlon. With over 150 charities signed up from 18
different women’s health causes, the Challenge has already raised over
$1 million to date.

“The Million Dollar Challenge and today’s check presentation to Dr.
Slamon are demonstrations of Revlon’s long-standing commitment to
women’s progress and health related issues,” said Fabian Garcia,
President and CEO of Revlon. “We are proud to support Dr. Slamon and his
pioneering research that has benefited the health and well-being of
millions of women around the world.”

About Revlon, Inc.

Revlon has developed a long-standing reputation as a color authority and
beauty trendsetter in the world of color cosmetics and hair care. Since
its breakthrough launch of the first opaque nail enamel in 1932, Revlon
has provided consumers with high quality product innovation, performance
and sophisticated glamour. In 2016, Revlon acquired the iconic Elizabeth
Arden® portfolio of brands, including its leading designer, heritage and
celebrity fragrances. Today, Revlon’s diversified portfolio of brands is
sold in more than 130 countries around the world in most retail
distribution channels, including mass, salon and prestige. Revlon ranks
among the top 20 global beauty companies, with product offerings in
color cosmetics, skincare, hair care and fragrances under brands such
as Revlon, Elizabeth Arden, Revlon ColorSilk, Revlon Professional,
American Crew, Almay, Cutex, Elizabeth Taylor, Britney Spears, Juicy
Couture, Curve, John Varvatos and Christina Aguilera. Please visit http://www.revlon.com for
the latest news and information about Revlon and its brands.

About Revlon Women’s Health Mission

Revlon is proudly committed to supporting women’s health. Over the last
25 years, Revlon, and its chairman, Ronald O. Perelman, have donated
over $150 million to women’s health causes. As a longstanding supporter
of women’s health, their combined contributions have benefited an array
of causes to eradicate women’s cancers, improve reproductive and
pre-natal medicine, support victims of domestic violence, and combat
women’s heart disease.

About UCLA’s Jonsson Comprehensive Cancer Center

UCLA’s Jonsson Comprehensive Cancer Center has more than 450 researchers
and clinicians engaged in disease research, prevention, detection,
control, treatment and education. One of the nation’s largest
comprehensive cancer centers, the Jonsson Cancer Center is dedicated to
promoting research and translating basic science into leading-edge
clinical studies. In July 2014, the Jonsson Cancer Center was named
among the top 10 cancer centers nationwide by U.S. News & World Report,
a ranking it has held for 14 years. To learn more about the center,
visit its web site at http://www.cancer.ucla.edu.

Contacts

Revlon
Victoria Ashley, 212-527-4137
Global Public Relations
Victoria.Ashley@revlon.com
or
UCLA’s
Jonsson Comprehensive Cancer Center
Peter Bracke, 310-206-2805
PBracke@mednet.ucla.edu